Our work is consistent with the idea that immune cells reacting to invading areas of a growing tumor generate IRF-1 in the tumor perhaps through release of IFN-γ, which eventually leads to AS to generate CEACAM1 L-isoform expression not only on T cells but in non-inflamed epithelial cells as well. The gene discussed is CEACAM1; the disease is neoplasm.